Pharmacological modulation of nucleic acid sensors — therapeutic potential and persisting obstacles
出版年份 2019 全文链接
标题
Pharmacological modulation of nucleic acid sensors — therapeutic potential and persisting obstacles
作者
关键词
-
出版物
NATURE REVIEWS DRUG DISCOVERY
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2019-09-25
DOI
10.1038/s41573-019-0043-2
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- STING-mediated intestinal barrier dysfunction contributes to lethal sepsis
- (2019) Qiongyuan Hu et al. EBioMedicine
- The STING agonist 5,6-dimethylxanthenone-4-acetic acid (DMXAA) stimulates an antiviral state and protects mice against herpes simplex virus-induced neurological disease
- (2019) Stacey Cerón et al. VIROLOGY
- RNA-based adjuvant CV8102 enhances the immunogenicity of a licensed rabies vaccine in a first-in-human trial
- (2019) Fatma Doener et al. VACCINE
- cGAS in action: Expanding roles in immunity and inflammation
- (2019) Andrea Ablasser et al. SCIENCE
- OAS-RNase L innate immune pathway mediates the cytotoxicity of a DNA-demethylating drug
- (2019) Shuvojit Banerjee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Drug developers switch gears to inhibit STING
- (2019) Cormac Sheridan NATURE BIOTECHNOLOGY
- TLR9-dependent interferon production prevents group 2 innate lymphoid cell-driven airway hyperreactivity
- (2019) Christina Li-Ping Thio et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Acetylation Blocks cGAS Activity and Inhibits Self-DNA-Induced Autoimmunity
- (2019) Jiang Dai et al. CELL
- Innate Immune Signaling Organelles Display Natural and Programmable Signaling Flexibility
- (2019) Yunhao Tan et al. CELL
- Effects of 24 Week Toll-Like Receptor 9 Agonist Treatment in HIV-1+ Individuals
- (2019) Line K. Vibholm et al. AIDS
- Pediatric Evans syndrome is associated with a high frequency of potentially damaging variants in immune genes
- (2019) Jérôme Hadjadj et al. BLOOD
- RGS1 silencing inhibits the inflammatory response and angiogenesis in rheumatoid arthritis rats through the inactivation of Toll‐like receptor signaling pathway
- (2019) Xumin Hu et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Systemic clinical tumor regressions and potentiation of PD1 blockade with in situ vaccination
- (2019) Linda Hammerich et al. NATURE MEDICINE
- Spotlight on anifrolumab and its potential for the treatment of moderate-to-severe systemic lupus erythematosus: evidence to date
- (2019) Renaud Felten et al. Drug Design Development and Therapy
- STING agonists activate latently infected cells and enhance SIV-specific responses ex vivo in naturally SIV controlled cynomolgus macaques
- (2019) Takuya Yamamoto et al. Scientific Reports
- Immunotherapeutic effects of intratumoral nanoplexed poly I:C
- (2019) M. Angela Aznar et al. Journal for ImmunoTherapy of Cancer
- Severe influenza pneumonitis in children with inherited TLR3 deficiency
- (2019) Hye Kyung Lim et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Mitochondrial DNA: A new driver for sex differences in spontaneous hypertension
- (2019) Cinthya Echem et al. PHARMACOLOGICAL RESEARCH
- Development of human cGAS-specific small-molecule inhibitors for repression of dsDNA-triggered interferon expression
- (2019) Lodoe Lama et al. Nature Communications
- Poly-ICLC, a TLR3 Agonist, Induces Transient Innate Immune Responses in Patients With Treated HIV-Infection: A Randomized Double-Blinded Placebo Controlled Trial
- (2019) Mansi Saxena et al. Frontiers in Immunology
- Combined immunotherapy encompassing intratumoral poly-ICLC, dendritic-cell vaccination and radiotherapy in advanced cancer patients
- (2018) M E Rodríguez-Ruiz et al. ANNALS OF ONCOLOGY
- Splicing variant ofWDFY4augments MDA5 signalling and the risk of clinically amyopathic dermatomyositis
- (2018) Yuta Kochi et al. ANNALS OF THE RHEUMATIC DISEASES
- RIG-I and Other RNA Sensors in Antiviral Immunity
- (2018) Kwan T. Chow et al. Annual Review of Immunology
- Effective cancer immunotherapy in mice by polyIC-imiquimod complexes and engineered magnetic nanoparticles
- (2018) Ana Isabel Bocanegra Gondan et al. BIOMATERIALS
- Recurrence of vulval intraepithelial neoplasia following treatment with cidofovir or imiquimod: results from a multicentre, randomised, phase II trial (RT3VIN)
- (2018) CN Hurt et al. BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY
- Cytosolic DNA Sensing in Organismal Tumor Control
- (2018) Claire Vanpouille-Box et al. CANCER CELL
- SnapShot: CGAS-STING Signaling
- (2018) Lorenzo Galluzzi et al. CELL
- Human ADAR1 Prevents Endogenous RNA from Triggering Translational Shutdown
- (2018) Hachung Chung et al. CELL
- Activation of Stimulator of Interferon Genes (STING) and Sjögren Syndrome
- (2018) J. Papinska et al. JOURNAL OF DENTAL RESEARCH
- Polyglutamine binding protein 1 (PQBP1) inhibits innate immune responses to cytosolic DNA
- (2018) Jessica L. Shannon et al. MOLECULAR IMMUNOLOGY
- Immunological Mechanisms Responsible for Radiation-Induced Abscopal Effect
- (2018) María E. Rodríguez-Ruiz et al. TRENDS IN IMMUNOLOGY
- TLR9 activation via microglial glucocorticoid receptors contributes to degeneration of midbrain dopamine neurons
- (2018) Layal Maatouk et al. Nature Communications
- Warming “Cold” Melanoma with TLR9 Agonists
- (2018) Cancer Discovery
- A novel anti-malarial drug derivative inhibits cyclic GMP-AMP synthase in Trex1 deficient mice
- (2018) Jie An et al. Arthritis & Rheumatology
- Anti-Melanoma immunity and local regression of cutaneous metastases in melanoma patients treated with monobenzone and imiquimod; a phase 2 a trial
- (2018) Hansje-Eva Teulings et al. OncoImmunology
- A minimal RNA ligand for potent RIG-I activation in living mice
- (2018) Melissa M. Linehan et al. Science Advances
- Mitochondrial double-stranded RNA triggers antiviral signalling in humans
- (2018) Ashish Dhir et al. NATURE
- Targeting STING with covalent small-molecule inhibitors
- (2018) Simone M. Haag et al. NATURE
- The hallmarks of successful anticancer immunotherapy
- (2018) Lorenzo Galluzzi et al. Science Translational Medicine
- In Situ Vaccination with a TLR9 Agonist and Local Low-Dose Radiation Induces Systemic Responses in Untreated Indolent Lymphoma
- (2018) Matthew J. Frank et al. Cancer Discovery
- SD-101 in Combination with Pembrolizumab in Advanced Melanoma: Results of a Phase Ib, Multicenter Study
- (2018) Antoni Ribas et al. Cancer Discovery
- ADAR1‐mediated RNA editing is required for thymic self‐tolerance and inhibition of autoimmunity
- (2018) Taisuke Nakahama et al. EMBO REPORTS
- Expression of STING Is Increased in Liver Tissues From Patients With NAFLD and Promotes Macrophage-Mediated Hepatic Inflammation and Fibrosis in Mice
- (2018) Xianjun Luo et al. GASTROENTEROLOGY
- STING-mediated inflammation in Kupffer cells contributes to progression of nonalcoholic steatohepatitis
- (2018) Yongsheng Yu et al. JOURNAL OF CLINICAL INVESTIGATION
- Systematic Screening of Commonly Used Commercial Transfection Reagents towards Efficient Transfection of Single-Stranded Oligonucleotides
- (2018) Tao Wang et al. MOLECULES
- Loss of ADAR1 in tumours overcomes resistance to immune checkpoint blockade
- (2018) Jeffrey J. Ishizuka et al. NATURE
- Design of amidobenzimidazole STING receptor agonists with systemic activity
- (2018) Joshi M. Ramanjulu et al. NATURE
- Linking cellular stress responses to systemic homeostasis
- (2018) Lorenzo Galluzzi et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- WDFY4 is required for cross-presentation in response to viral and tumor antigens
- (2018) Derek J. Theisen et al. SCIENCE
- Identification of ADAR1 adenosine deaminase dependency in a subset of cancer cells
- (2018) Hugh S. Gannon et al. Nature Communications
- Magnitude of Therapeutic STING Activation Determines CD8+ T Cell-Mediated Anti-tumor Immunity
- (2018) Kelsey E. Sivick et al. Cell Reports
- The Cyclopeptide Astin C Specifically Inhibits the Innate Immune CDN Sensor STING
- (2018) Senlin Li et al. Cell Reports
- Trial Watch: Toll-like receptor agonists in cancer immunotherapy
- (2018) Melody Smith et al. OncoImmunology
- Absence of RNase H2 triggers generation of immunogenic micronuclei removed by autophagy
- (2017) Kareen Bartsch et al. HUMAN MOLECULAR GENETICS
- Recurrent rhinovirus infections in a child with inherited MDA5 deficiency
- (2017) Ian T. Lamborn et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Vaccination with poly(IC:LC) and peptide-pulsed autologous dendritic cells in patients with pancreatic cancer
- (2017) Shikhar Mehrotra et al. Journal of Hematology & Oncology
- Cutting Edge: Activation of STING in T Cells Induces Type I IFN Responses and Cell Death
- (2017) Bridget Larkin et al. JOURNAL OF IMMUNOLOGY
- SB 9200, a novel agonist of innate immunity, shows potent antiviral activity against resistant HCV variants
- (2017) Meleri Jones et al. JOURNAL OF MEDICAL VIROLOGY
- HIV-1–Associated Atherosclerosis
- (2017) Alison Kearns et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- 5′-Triphosphate siRNA targeting MDR1 reverses multi-drug resistance and activates RIG-I-induced immune-stimulatory and apoptotic effects against human myeloid leukaemia cells
- (2017) Dengzhe Li et al. LEUKEMIA RESEARCH
- The TLR9 agonist MGN1703 triggers a potent type I interferon response in the sigmoid colon
- (2017) A R Krarup et al. Mucosal Immunology
- IRF3 and type I interferons fuel a fatal response to myocardial infarction
- (2017) Kevin R King et al. NATURE MEDICINE
- cGAS drives noncanonical-inflammasome activation in age-related macular degeneration
- (2017) Nagaraj Kerur et al. NATURE MEDICINE
- Pharmacological modulation of autophagy: therapeutic potential and persisting obstacles
- (2017) Lorenzo Galluzzi et al. NATURE REVIEWS DRUG DISCOVERY
- Beyond TNF: TNF superfamily cytokines as targets for the treatment of rheumatic diseases
- (2017) Michael Croft et al. Nature Reviews Rheumatology
- Antiviral Efficacy and Host Immune Response Induction during Sequential Treatment with SB 9200 Followed by Entecavir in Woodchucks
- (2017) Manasa Suresh et al. PLoS One
- CRISPR-Cas: Adapting to change
- (2017) Simon A. Jackson et al. SCIENCE
- Human innate responses and adjuvant activity of TLR ligands in vivo in mice reconstituted with a human immune system
- (2017) Liang Cheng et al. VACCINE
- A small-molecule IRF3 agonist functions as an influenza vaccine adjuvant by modulating the antiviral immune response
- (2017) Peter Probst et al. VACCINE
- Signalling strength determines proapoptotic functions of STING
- (2017) Muhammet F. Gulen et al. Nature Communications
- IFI16 and cGAS cooperate in the activation of STING during DNA sensing in human keratinocytes
- (2017) Jessica F. Almine et al. Nature Communications
- DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity
- (2017) Claire Vanpouille-Box et al. Nature Communications
- Hepatitis C virus and atherosclerosis: A legacy after virologic cure?
- (2017) M.F. Bassendine et al. Clinics and Research in Hepatology and Gastroenterology
- NAB2 is a novel immune stimulator of MDA-5 that promotes a strong type I interferon response
- (2017) Anne Oberson et al. Oncotarget
- A TLR3-Specific Adjuvant Relieves Innate Resistance to PD-L1 Blockade without Cytokine Toxicity in Tumor Vaccine Immunotherapy
- (2017) Yohei Takeda et al. Cell Reports
- Intratumoral STING Activation with T-cell Checkpoint Modulation Generates Systemic Antitumor Immunity
- (2017) Casey R. Ager et al. Cancer Immunology Research
- Natural Modulators of Endosomal Toll-Like Receptor-Mediated Psoriatic Skin Inflammation
- (2017) Chao-Yang Lai et al. Journal of Immunology Research
- The STING agonist DMXAA triggers a cooperation between T lymphocytes and myeloid cells that leads to tumor regression
- (2017) Julia M. Weiss et al. OncoImmunology
- Topical Imiquimod Plus Nab-paclitaxel for Breast Cancer Cutaneous Metastases
- (2017) Lupe G. Salazar et al. JAMA Oncology
- A pilot study of the immunogenicity of a 9-peptide breast cancer vaccine plus poly-ICLC in early stage breast cancer
- (2017) Patrick M. Dillon et al. Journal for ImmunoTherapy of Cancer
- Chlamydia Pneumoniae and Atherosclerosis: Current State and Future Prospectives
- (2017) R. Sessa et al. INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY
- Agonist-Mediated Activation of STING Induces Apoptosis in Malignant B Cells
- (2016) Chih-Hang Anthony Tang et al. CANCER RESEARCH
- Recognition of Endogenous Nucleic Acids by the Innate Immune System
- (2016) Axel Roers et al. IMMUNITY
- Strategies for designing synthetic immune agonists
- (2016) Tom Y.-H. Wu IMMUNOLOGY
- Imiquimod in dermatology: an overview
- (2016) Edith Hanna et al. INTERNATIONAL JOURNAL OF DERMATOLOGY
- Dyschromatosis Symmetrica Hereditaria and Aicardi-Goutières Syndrome 6 Are Phenotypic Variants Caused by ADAR1 Mutations
- (2016) Michihiro Kono et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Innate Immunity Stimulation via Toll-Like Receptor 9 Ameliorates Vascular Amyloid Pathology in Tg-SwDI Mice with Associated Cognitive Benefits
- (2016) Henrieta Scholtzova et al. JOURNAL OF NEUROSCIENCE
- Induction of humoral and cellular immune response to hepatitis B virus (HBV) vaccine can be upregulated by CpG oligonucleotides complexed with Dectin-1 ligand
- (2016) H. Ito et al. JOURNAL OF VIRAL HEPATITIS
- Viral evasion of intracellular DNA and RNA sensing
- (2016) Ying Kai Chan et al. NATURE REVIEWS MICROBIOLOGY
- Functional polymorphisms of the TLR7 and TLR8 genes contribute to Mycobacterium tuberculosis infection
- (2016) Yung-Fa Lai et al. TUBERCULOSIS
- Cancer therapies activate RIG-I-like receptor pathway through endogenous non-coding RNAs
- (2016) Diana Rose E. Ranoa et al. Oncotarget
- STING Pathway Activation Stimulates Potent Immunity against Acute Myeloid Leukemia
- (2016) Emily Curran et al. Cell Reports
- Which therapeutic strategy will achieve a cure for HIV-1?
- (2016) Anthony R Cillo et al. Current Opinion in Virology
- Antiviral Efficacy and Host Innate Immunity Associated with SB 9200 Treatment in the Woodchuck Model of Chronic Hepatitis B
- (2016) Kyle E. Korolowicz et al. PLoS One
- Topical resiquimod can induce disease regression and enhance T-cell effector functions in cutaneous T-cell lymphoma
- (2015) A. H. Rook et al. BLOOD
- Early clinical evaluation of the intranasal TLR7 agonist GSK2245035: Use of translational biomarkers to guide dosing and confirm target engagement
- (2015) D Tsitoura et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Oligodeoxynucleotide inhibition of Toll-like receptors 3, 7, 8, and 9 suppresses cytokine production in a human rheumatoid arthritis model
- (2015) Sandra Sacre et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Sex hormone affects the severity of non-alcoholic steatohepatitis through the MyD88-dependent IL-6 signaling pathway
- (2015) Guangda Xin et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- Isoforms of RNA-Editing Enzyme ADAR1 Independently Control Nucleic Acid Sensor MDA5-Driven Autoimmunity and Multi-organ Development
- (2015) Kathleen Pestal et al. IMMUNITY
- Sequential Activation of Two Pathogen-Sensing Pathways Required for Type I Interferon Expression and Resistance to an Acute DNA Virus Infection
- (2015) Ren-Huan Xu et al. IMMUNITY
- Inhibition of indoleamine 2,3-dioxygenase activity enhances the anti-tumour effects of a Toll-like receptor 7 agonist in an established cancer model
- (2015) Hiroyasu Ito et al. IMMUNOLOGY
- Toll-like receptor 8 deletion accelerates autoimmunity in a mouse model of lupus through a Toll-like receptor 7-dependent mechanism
- (2015) Ngoc Lan Tran et al. IMMUNOLOGY
- Cutting Edge: Inhibiting TBK1 by Compound II Ameliorates Autoimmune Disease in Mice
- (2015) Maroof Hasan et al. JOURNAL OF IMMUNOLOGY
- RIG-I contributes to the innate immune response after cerebral ischemia
- (2015) Frank J. Brand et al. Journal of Inflammation-London
- RNA editing by ADAR1 prevents MDA5 sensing of endogenous dsRNA as nonself
- (2015) B. J. Liddicoat et al. SCIENCE
- Hepatitis B surface antigen (HBsAg) and core antigen (HBcAg) combine CpG oligodeoxynucletides as a novel therapeutic vaccine for chronic hepatitis B infection
- (2015) Jianqiang Li et al. VACCINE
- Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity
- (2015) Leticia Corrales et al. Cell Reports
- BRCA1 Regulates IFI16 Mediated Nuclear Innate Sensing of Herpes Viral DNA and Subsequent Induction of the Innate Inflammasome and Interferon-β Responses
- (2015) Dipanjan Dutta et al. PLoS Pathogens
- Promotion of Inflammatory Arthritis by Interferon Regulatory Factor 5 in a Mouse Model
- (2015) Pierre Duffau et al. Arthritis & Rheumatology
- Resiquimod as an Immunologic Adjuvant for NY-ESO-1 Protein Vaccination in Patients with High-Risk Melanoma
- (2015) R. L. Sabado et al. Cancer Immunology Research
- STING Agonists Induce an Innate Antiviral Immune Response against Hepatitis B Virus
- (2014) Fang Guo et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Using Poly I:C as an adjuvant does not induce or exacerbate models of systemic lupus erythematosus
- (2014) Tami Annable et al. AUTOIMMUNITY
- Induction of Robust Type-I CD8+ T-cell Responses in WHO Grade 2 Low-Grade Glioma Patients Receiving Peptide-Based Vaccines in Combination with Poly-ICLC
- (2014) H. Okada et al. CLINICAL CANCER RESEARCH
- STING-Dependent Cytosolic DNA Sensing Mediates Innate Immune Recognition of Immunogenic Tumors
- (2014) Seng-Ryong Woo et al. IMMUNITY
- STING-Dependent Cytosolic DNA Sensing Promotes Radiation-Induced Type I Interferon-Dependent Antitumor Immunity in Immunogenic Tumors
- (2014) Liufu Deng et al. IMMUNITY
- The role of TLR9 polymorphism in susceptibility to pulmonary tuberculosis
- (2014) Deepak Bharti et al. IMMUNOGENETICS
- Antigen-Specific Immune Responses and Clinical Outcome After Vaccination With Glioma-Associated Antigen Peptides and Polyinosinic-Polycytidylic Acid Stabilized by Lysine and Carboxymethylcellulose in Children With Newly Diagnosed Malignant Brainstem and Nonbrainstem Gliomas
- (2014) Ian F. Pollack et al. JOURNAL OF CLINICAL ONCOLOGY
- Identification of RNA Sequence Motifs Stimulating Sequence-Specific TLR8-Dependent Immune Responses
- (2014) A. Forsbach et al. JOURNAL OF IMMUNOLOGY
- Endosomal Localization of TLR8 Confers Distinctive Proteolytic Processing on Human Myeloid Cells
- (2014) Noriko Ishii et al. JOURNAL OF IMMUNOLOGY
- Inhibition of Dengue and Chikungunya Virus Infections by RIG-I-Mediated Type I Interferon-Independent Stimulation of the Innate Antiviral Response
- (2014) D. Olagnier et al. JOURNAL OF VIROLOGY
- Yeast Virus-Derived Stimulator of the Innate Immune System Augments the Efficacy of Virus Vector-Based Immunotherapy
- (2014) M.-C. Claudepierre et al. JOURNAL OF VIROLOGY
- Hydrolysis of 2′3′-cGAMP by ENPP1 and design of nonhydrolyzable analogs
- (2014) Lingyin Li et al. Nature Chemical Biology
- Cancer cell–autonomous contribution of type I interferon signaling to the efficacy of chemotherapy
- (2014) Antonella Sistigu et al. NATURE MEDICINE
- The mechanism of action of BCG therapy for bladder cancer—a current perspective
- (2014) Gil Redelman-Sidi et al. Nature Reviews Urology
- MyD88 and TLR9 Dependent Immune Responses Mediate Resistance to Leishmania guyanensis Infections, Irrespective of Leishmania RNA Virus Burden
- (2014) Annette Ives et al. PLoS One
- Inflammation-driven carcinogenesis is mediated through STING
- (2014) Jeonghyun Ahn et al. Nature Communications
- Genetic variations in Toll-like receptors (TLRs 3/7/8) are associated with systemic lupus erythematosus in a Taiwanese population
- (2014) Chin-Man Wang et al. Scientific Reports
- STING Contributes to Antiglioma Immunity via Triggering Type I IFN Signals in the Tumor Microenvironment
- (2014) T. Ohkuri et al. Cancer Immunology Research
- STING Ligand c-di-GMP Improves Cancer Vaccination against Metastatic Breast Cancer
- (2014) D. Chandra et al. Cancer Immunology Research
- Pattern Recognition and Signaling Mechanisms of RIG-I and MDA5
- (2014) Stephanie Reikine et al. Frontiers in Immunology
- TLR7 Expression is Decreased During Tumour Progression in Transgenic Adenocarcinoma of Mouse Prostate Mice and Its Activation Inhibits Growth of Prostate Cancer Cells
- (2013) Ju-Hee Han et al. AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY
- TLR8 stimulation enhances cetuximab-mediated natural killer cell lysis of head and neck cancer cells and dendritic cell cross-priming of EGFR-specific CD8+ T cells
- (2013) Ryan M. Stephenson et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Structure-Function Analysis of STING Activation by c[G(2′,5′)pA(3′,5′)p] and Targeting by Antiviral DMXAA
- (2013) Pu Gao et al. CELL
- Cyclic [G(2′,5′)pA(3′,5′)p] Is the Metazoan Second Messenger Produced by DNA-Activated Cyclic GMP-AMP Synthase
- (2013) Pu Gao et al. CELL
- The eIF2α kinases: their structures and functions
- (2013) Neysan Donnelly et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Mouse, but not Human STING, Binds and Signals in Response to the Vascular Disrupting Agent 5,6-Dimethylxanthenone-4-Acetic Acid
- (2013) J. Conlon et al. JOURNAL OF IMMUNOLOGY
- cGAS produces a 2′-5′-linked cyclic dinucleotide second messenger that activates STING
- (2013) Andrea Ablasser et al. NATURE
- Structural mechanism of cytosolic DNA sensing by cGAS
- (2013) Filiz Civril et al. NATURE
- Cell intrinsic immunity spreads to bystander cells via the intercellular transfer of cGAMP
- (2013) Andrea Ablasser et al. NATURE
- Single Nucleotide Polymorphisms of Human STING Can Affect Innate Immune Response to Cyclic Dinucleotides
- (2013) Guanghui Yi et al. PLoS One
- DNA damage sensor MRE11 recognizes cytosolic double-stranded DNA and induces type I interferon by regulating STING trafficking
- (2013) T. Kondo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Pivotal Roles of cGAS-cGAMP Signaling in Antiviral Defense and Immune Adjuvant Effects
- (2013) X.-D. Li et al. SCIENCE
- Cyclic GMP-AMP Synthase Is an Innate Immune Sensor of HIV and Other Retroviruses
- (2013) D. Gao et al. SCIENCE
- Aldara activates TLR7-independent immune defence
- (2013) Anne Walter et al. Nature Communications
- Systems Analysis of a RIG-I Agonist Inducing Broad Spectrum Inhibition of Virus Infectivity
- (2013) Marie-Line Goulet et al. PLoS Pathogens
- Targeting Toll-Like Receptors: Promising Therapeutic Strategies for the Management of Sepsis-Associated Pathology and Infectious Diseases
- (2013) Athina Savva et al. Frontiers in Immunology
- Blocking Toll-Like Receptors 7 and 9 Reduces Postinterventional Remodeling via Reduced Macrophage Activation, Foam Cell Formation, and Migration
- (2012) Jacco C. Karper et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- R-848 triggers the expression of TLR7/8 and suppresses HIV replication in monocytes
- (2012) Hua Nian et al. BMC INFECTIOUS DISEASES
- Toll-Like Receptor 7 Protects From Atherosclerosis by Constraining “Inflammatory” Macrophage Activation
- (2012) Maria Salagianni et al. CIRCULATION
- Synergy of Topical Toll-like Receptor 7 Agonist with Radiation and Low-Dose Cyclophosphamide in a Mouse Model of Cutaneous Breast Cancer
- (2012) M. Z. Dewan et al. CLINICAL CANCER RESEARCH
- 5,6-Dimethylxanthenone-4-acetic Acid (DMXAA) Activates Stimulator of Interferon Gene (STING)-dependent Innate Immune Pathways and Is Regulated by Mitochondrial Membrane Potential
- (2012) Daniel Prantner et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Sequential induction of type I and II interferons mediates a long-lasting gene induction in the liver in response to a novel toll-like receptor 9 agonist
- (2012) Zuzanna Makowska et al. JOURNAL OF HEPATOLOGY
- Mitochondrial DNA that escapes from autophagy causes inflammation and heart failure
- (2012) Takafumi Oka et al. NATURE
- The helicase DDX41 recognizes the bacterial secondary messengers cyclic di-GMP and cyclic di-AMP to activate a type I interferon immune response
- (2012) Kislay Parvatiyar et al. NATURE IMMUNOLOGY
- Silencing of Irf7 pathways in breast cancer cells promotes bone metastasis through immune escape
- (2012) Bradley N Bidwell et al. NATURE MEDICINE
- An unconventional role for miRNA: let-7 activates Toll-like receptor 7 and causes neurodegeneration
- (2012) Sabrina M Lehmann et al. NATURE NEUROSCIENCE
- Modulating immunity as a therapy for bacterial infections
- (2012) Robert E. W. Hancock et al. NATURE REVIEWS MICROBIOLOGY
- A Double-Blind, Placebo-Controlled, Randomized, Clinical Trial of the TLR-3 Agonist Rintatolimod in Severe Cases of Chronic Fatigue Syndrome
- (2012) David R. Strayer et al. PLoS One
- Cyclic GMP-AMP Synthase Is a Cytosolic DNA Sensor That Activates the Type I Interferon Pathway
- (2012) L. Sun et al. SCIENCE
- Investigation of the role of endosomal Toll-like receptors in murine collagen-induced arthritis reveals a potential role for TLR7 in disease maintenance
- (2012) Saba Alzabin et al. ARTHRITIS RESEARCH & THERAPY
- DNA-PK is a DNA sensor for IRF-3-dependent innate immunity
- (2012) Brian J Ferguson et al. eLife
- MyD88 Deficiency Ameliorates β-Amyloidosis in an Animal Model of Alzheimer's Disease
- (2011) Jeong-Eun Lim et al. AMERICAN JOURNAL OF PATHOLOGY
- A phase III randomized study of gemcitabine and cisplatin with or without PF-3512676 (TLR9 agonist) as first-line treatment of advanced non-small-cell lung cancer
- (2011) C. Manegold et al. ANNALS OF ONCOLOGY
- VTX-2337 Is a Novel TLR8 Agonist That Activates NK Cells and Augments ADCC
- (2011) H. Lu et al. CLINICAL CANCER RESEARCH
- CpG Blocks Immunosuppression by Myeloid-Derived Suppressor Cells in Tumor-Bearing Mice
- (2011) C. Zoglmeier et al. CLINICAL CANCER RESEARCH
- Toll-like receptor 3, RIG-I-like receptors and the NLRP3 inflammasome: Key modulators of innate immune responses to double-stranded RNA viruses
- (2011) Man Yu et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Pivotal Role of Dermal IL-17-Producing γδ T Cells in Skin Inflammation
- (2011) Yihua Cai et al. IMMUNITY
- Randomized Phase III Placebo-Controlled Trial of Carboplatin and Paclitaxel With or Without the Vascular Disrupting Agent Vadimezan (ASA404) in Advanced Non–Small-Cell Lung Cancer
- (2011) Primo N. Lara et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized Phase III Trial of Paclitaxel/Carboplatin With or Without PF-3512676 (Toll-Like Receptor 9 Agonist) As First-Line Treatment for Advanced Non–Small-Cell Lung Cancer
- (2011) Vera Hirsh et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase I clinical trial of CpG oligonucleotide 7909 (PF-03512676) in patients with previously treated chronic lymphocytic leukemia
- (2011) Clive S. Zent et al. LEUKEMIA & LYMPHOMA
- STING is a direct innate immune sensor of cyclic di-GMP
- (2011) Dara L. Burdette et al. NATURE
- Intracerebral administration of CpG oligonucleotide for patients with recurrent glioblastoma: a phase II study
- (2011) A. Carpentier et al. NEURO-ONCOLOGY
- Microglial glucocorticoid receptors play a pivotal role in regulating dopaminergic neurodegeneration in parkinsonism
- (2011) F. Ros-Bernal et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Antiviral responses induced by the TLR3 pathway
- (2011) Misako Matsumoto et al. REVIEWS IN MEDICAL VIROLOGY
- Therapeutic Targeting of TLR9 Inhibits Cell Growth and Induces Apoptosis in Neuroblastoma
- (2010) C. Brignole et al. CANCER RESEARCH
- Phase II Study on the Addition of ASA404 (Vadimezan; 5,6-Dimethylxanthenone-4-Acetic Acid) to Docetaxel in CRMPC
- (2010) R. Pili et al. CLINICAL CANCER RESEARCH
- TLR9 Regulates TLR7- and MyD88-Dependent Autoantibody Production and Disease in a Murine Model of Lupus
- (2010) Kevin M. Nickerson et al. JOURNAL OF IMMUNOLOGY
- Targeting Toll-like receptors: emerging therapeutics?
- (2010) Elizabeth J. Hennessy et al. NATURE REVIEWS DRUG DISCOVERY
- Contrasting Roles for TLR Ligands in HIV-1 Pathogenesis
- (2010) Beda Brichacek et al. PLoS One
- Genome-Wide Association Study in Asian Populations Identifies Variants in ETS1 and WDFY4 Associated with Systemic Lupus Erythematosus
- (2010) Wanling Yang et al. PLoS Genetics
- Randomized phase 2/3 trial of CpG oligodeoxynucleotide PF-3512676 alone or with dacarbazine for patients with unresectable stage III and IV melanoma
- (2009) Jeffrey S. Weber et al. CANCER
- Targeted Activation of Innate Immunity for Therapeutic Induction of Autophagy and Apoptosis in Melanoma Cells
- (2009) Damià Tormo et al. CANCER CELL
- RNA Polymerase III Detects Cytosolic DNA and Induces Type I Interferons through the RIG-I Pathway
- (2009) Yu-Hsin Chiu et al. CELL
- Safety and Efficacy of PF-3512676 for the Treatment of Stage IV Renal Cell Carcinoma: An Open-Label, Multicenter Phase I/II Study
- (2009) John A. Thompson et al. Clinical Genitourinary Cancer
- Alternating 2′-O-ribose methylation is a universal approach for generating non-stimulatory siRNA by acting as TLR7 antagonist
- (2009) Svetlana Hamm et al. IMMUNOBIOLOGY
- Polymorphisms and haplotypes in TLR9 and MYD88 are associated with the development of Hodgkin's lymphoma: a candidate–gene association study
- (2009) Vassiliki Mollaki et al. JOURNAL OF HUMAN GENETICS
- Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice Is Mediated via the IL-23/IL-17 Axis
- (2009) L. van der Fits et al. JOURNAL OF IMMUNOLOGY
- Reversal of Human Papillomavirus-Specific T Cell Immune Suppression through TLR Agonist Treatment of Langerhans Cells Exposed to Human Papillomavirus Type 16
- (2009) L. M. Fahey et al. JOURNAL OF IMMUNOLOGY
- AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC
- (2009) Veit Hornung et al. NATURE
- Nod1 and Nod2 direct autophagy by recruiting ATG16L1 to the plasma membrane at the site of bacterial entry
- (2009) Leonardo H Travassos et al. NATURE IMMUNOLOGY
- Endosomal TLR signaling is required for anti-nucleic acid and rheumatoid factor autoantibodies in lupus
- (2009) D. H. Kono et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- DNA-like class R inhibitory oligonucleotides (INH-ODNs) preferentially block autoantigen-induced B-cell and dendritic cell activation in vitro and autoantibody production in lupus-prone MRL-Faslpr/lpr mice in vivo
- (2009) Petar Lenert et al. ARTHRITIS RESEARCH & THERAPY
- Overexpression of toll-like receptors 3 and 4 in synovial tissue from patients with early rheumatoid arthritis: Toll-like receptor expression in early and longstanding arthritis
- (2008) Caroline Ospelt et al. ARTHRITIS AND RHEUMATISM
- T-cell modulation combined with intratumoral CpG cures lymphoma in a mouse model without the need for chemotherapy
- (2008) R. Houot et al. BLOOD
- CPG 7909 Adjuvant plus Hepatitis B Virus Vaccination in HIV‐Infected Adults Achieves Long‐Term Seroprotection for Up to 5 Years
- (2008) C. L. Cooper et al. CLINICAL INFECTIOUS DISEASES
- Randomized Phase II Trial of a Toll-Like Receptor 9 Agonist Oligodeoxynucleotide, PF-3512676, in Combination With First-Line Taxane Plus Platinum Chemotherapy for Advanced-Stage Non–Small-Cell Lung Cancer
- (2008) Christian Manegold et al. JOURNAL OF CLINICAL ONCOLOGY
- 5′-triphosphate-siRNA: turning gene silencing and Rig-I activation against melanoma
- (2008) Hendrik Poeck et al. NATURE MEDICINE
- Interferon signaling and treatment outcome in chronic hepatitis C
- (2008) M. Sarasin-Filipowicz et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now